Biotech startup uses tobacco plants to make vaccines

03/22/2012 | InnovationNewsDaily.com

U.S. biotech startup Inserogen has transformed tobacco plants into biological factories for manufacturing proteins for new vaccines and treatments. Using the SwiftVax tobacco plants, the startup is developing a vaccine for Newcastle disease, and a therapeutic protein for patients with alpha-1 antitrypsin deficiency. "The technology is easy to customize, and can be engineered to produce not only vaccines, but virtually any recombinant protein," Inserogen's Lucas Arzola said.

View Full Article in:

InnovationNewsDaily.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ